Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
08 2019
Historique:
received: 03 05 2019
accepted: 24 05 2019
pubmed: 5 6 2019
medline: 9 6 2020
entrez: 5 6 2019
Statut: epublish

Résumé

Fosfomycin tromethamine activity is well established for oral treatment of uncomplicated lower urinary tract infections, but little is known about its potential efficacy in pyelonephritis. Ascending pyelonephritis was induced in mice infected with 6 strains of

Identifiants

pubmed: 31160291
pii: AAC.00903-19
doi: 10.1128/AAC.00903-19
pmc: PMC6658801
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fosfomycin 2N81MY12TE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Eur Urol. 2001 Nov;40(5):576-88
pubmed: 11752870
J Antimicrob Chemother. 2007 Feb;59(2):165-74
pubmed: 17158117
Antimicrob Agents Chemother. 2012 Mar;56(3):1376-81
pubmed: 22214774
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038268
Front Cell Infect Microbiol. 2017 Jun 08;7:241
pubmed: 28642845
Antibiotics (Basel). 2017 Oct 31;6(4):
pubmed: 29088073
Mol Microbiol. 1992 Feb;6(4):555-62
pubmed: 1560784
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28396549
Emerg Infect Dis. 2008 Feb;14(2):195-200
pubmed: 18258110
Nat Rev Microbiol. 2010 Mar;8(3):207-17
pubmed: 20157339
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28607025
Infect Immun. 1990 May;58(5):1281-9
pubmed: 2182540
J Antimicrob Chemother. 2013 Mar;68(3):562-8
pubmed: 23143897
FEMS Immunol Med Microbiol. 2005 Jun 1;44(3):317-21
pubmed: 15907455
Appl Environ Microbiol. 2000 Oct;66(10):4555-8
pubmed: 11010916
Int J Med Microbiol. 2017 Dec;307(8):452-459
pubmed: 28986014
Pharmacology. 2012;90(5-6):281-7
pubmed: 23037005
Drugs. 1997 Apr;53(4):637-56
pubmed: 9098664
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630194
J Antimicrob Chemother. 2012 Feb;67(2):255-68
pubmed: 22096042
Lancet Infect Dis. 2010 Jan;10(1):43-50
pubmed: 20129148
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29581117
Clin Infect Dis. 2015 Oct 1;61(7):1141-3
pubmed: 26063723
Antimicrob Agents Chemother. 2003 Sep;47(9):2850-8
pubmed: 12936984
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9
pubmed: 14527772
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891606
EMBO J. 1985 Dec 30;4(13B):3887-93
pubmed: 2868893

Auteurs

Annabelle Pourbaix (A)

INSERM, IAME, UMR 1137, Paris, France.
Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.

François Guérin (F)

Université de Caen Normandie, EA 4655 (équipe Antibio-résistance), Caen, France.
CHU de Caen, Service de Microbiologie, Caen, France.

Charles Burdet (C)

INSERM, IAME, UMR 1137, Paris, France.
Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.

Laurent Massias (L)

INSERM, IAME, UMR 1137, Paris, France.
AP-HP, Groupe Hospitalier Paris Nord Val de Seine, Laboratoire de Pharmacologie et Toxicologie, Paris, France.

Françoise Chau (F)

INSERM, IAME, UMR 1137, Paris, France.
Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.

Vincent Cattoir (V)

CHU de Rennes, Service de Bactériologie-Hygiène Hospitalière & CNR de la Résistance aux Antibiotiques, Rennes, France.
Université de Rennes 1, Unité INSERM U1230, Rennes, France.

Bruno Fantin (B)

INSERM, IAME, UMR 1137, Paris, France bruno.fantin@aphp.fr.
Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.
AP-HP, Groupe Hospitalier Paris Nord Val de Seine, Service de Médecine Interne, Clichy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH